RecruitingNCT06514560

OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Tropical Medicine, Belgium
Principal Investigator
Saskia Van Henten
Institute of Tropical Medicine
Intervention
Miltefosine(drug)
Enrollment
80 target
Eligibility
2 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

Alert Hospital, Ethiopia · Armauer Hansen Research Institute, Ethiopia · Uppsala University · The Netherlands Cancer Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06514560 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials